Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Patrycja Fryzik

PhD student
Underlying causes of pediatric MDS and bone marrow failure 

Pediatric myelodysplastic syndrome (MDS) is a pre-malignant bone marrow failure disorder of the hematopoietic system. Currently, the only curative option for MDS patients is a hematopoietic stem cell transplant, which carries significant risks, including severe morbidity and potentially life-threatening treatment-related complications. However, development of new therapies is limited by the insufficient understanding of the disease mechanisms.  

 

In my research, I seek to uncover the underlying causes of pediatric MDS, identify novel therapeutic targets and gain deeper insight into why and how bone marrow failure occurs. By applying advanced (single-cell) sequencing techniques, such as CITE-seq and spatial transcriptomics, I aim to dissect the mechanisms driving MDS development and progression. These approaches will help to identify aberrant genes, pathways and interactions of the failing bone marrow – ultimately leading to deeper understanding of MDS and hopefully making a positive impact on the wellbeing and prognosis of children diagnosed with MDS.